BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29441946)

  • 1. Perphenazine and prochlorperazine induce concentration-dependent loss in human glioblastoma cells viability.
    Otręba M; Buszman E
    Pharmazie; 2018 Jan; 73(1):19-21. PubMed ID: 29441946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimelanoma activity of perphenazine and prochlorperazine in human COLO829 and C32 cell lines.
    Otręba M; Pajor M; Warncke JD
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Oct; 392(10):1257-1264. PubMed ID: 31172223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro anticancer activity of fluphenazine, perphenazine and prochlorperazine. A review.
    Otręba M; Kośmider L
    J Appl Toxicol; 2021 Jan; 41(1):82-94. PubMed ID: 32852120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prochlorperazine interaction with melanin and melanocytes.
    Otręba M; Wrześniok D; Rok J; Beberok A; Buszman E
    Pharmazie; 2017 Mar; 72(3):171-176. PubMed ID: 29442053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perphenazine and prochlorperazine decrease glioblastoma U-87 MG cell migration and invasion: Analysis of the ABCB1 and ABCG2 transporters, E-cadherin, α-tubulin and integrins (α3, α5, and β1) levels.
    Otręba M; Stojko J; Kabała-Dzik A; Rzepecka-Stojko A
    Oncol Lett; 2022 Jun; 23(6):182. PubMed ID: 35527777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic activity of some phenothiazine derivatives against neurohumoral transmitters.
    Saxena PN; Johri MB
    Jpn J Pharmacol; 1973 Jun; 23(3):363-71. PubMed ID: 4146777
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the use of some antiemetic substances in experimental acute intestinal occlusion].
    CUCINOTTA U
    Riv Patol Clin; 1959 Nov; 14():774-9. PubMed ID: 13813201
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines.
    Harvey KA; Xu Z; Saaddatzadeh MR; Wang H; Pollok K; Cohen-Gadol AA; Siddiqui RA
    J Neurosurg; 2015 Mar; 122(3):547-56. PubMed ID: 25526274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiemetic effect of perphenazine versus prochlorperazine intravenously before cisplatin therapy.
    Smaglia RA; Parkinson DR; Taylor CD
    Clin Pharm; 1984; 3(1):68-71. PubMed ID: 6365417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Micro-calorimetric analysis of the influence of various derivatives of phenothiazine: prochlorperazine, aminopromazine, levomepromazine, perphenazine, on heat production in the mouse].
    PRAT H
    Therapie; 1959; 14():594-602. PubMed ID: 14434656
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of dopamine and neuroleptics on plasma growth hormone and prolactin in normal men.
    Langer G; Sachar EJ; Halpern FS
    Psychoneuroendocrinology; 1978 Apr; 3(2):165-9. PubMed ID: 704750
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification of the receptor component of adenylate cyclase in the rat brain by phenothiazine derivatives.
    Palmer GC; Manian AA
    Neuropharmacology; 1974 Sep; 13(9):851-66. PubMed ID: 4154419
    [No Abstract]   [Full Text] [Related]  

  • 13. The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.
    Hempel C; Nörenberg W; Sobottka H; Urban N; Nicke A; Fischer W; Schaefer M
    Neuropharmacology; 2013 Dec; 75():365-79. PubMed ID: 23954492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing of antipsychotics perphenazine for the treatment of endometrial cancer.
    Chen Y; Cui Y; Sun X; Wu H; Ou M; Tang Y; Ni S; Li X; Zhu J; Mao F; Wang Y; Li J
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127239. PubMed ID: 32527541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic and apoptotic effects of bortezomib and gefitinib compared to alkylating agents on human glioblastoma cells.
    Pédeboscq S; L'Azou B; Passagne I; De Giorgi F; Ichas F; Pometan JP; Cambar J
    J Exp Ther Oncol; 2008; 7(2):99-111. PubMed ID: 18771084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLUPHENAZINE AND PERPHENAZINE IMPACT ON MELANOGENESIS AND ANTIOXIDANT ENZYMES ACTIVITY IN NORMAL HUMAN MELANOCYTES.
    Otreba M; Wrześniok D; Beberok A; Rok J; Buszman E
    Acta Pol Pharm; 2016 Jul; 73(4):903-911. PubMed ID: 29648716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma treatment using perphenazine to block the subventricular zone's tumor trophic functions.
    Kast RE; Ellingson BM; Marosi C; Halatsch ME
    J Neurooncol; 2014 Jan; 116(2):207-12. PubMed ID: 24242756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
    Pajak B; Molnar J; Engi H; Orzechowski A
    In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumors.
    Castellano S; Taliani S; Viviano M; Milite C; Da Pozzo E; Costa B; Barresi E; Bruno A; Cosconati S; Marinelli L; Greco G; Novellino E; Sbardella G; Da Settimo F; Martini C
    J Med Chem; 2014 Mar; 57(6):2413-28. PubMed ID: 24580635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.
    Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS
    J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.